These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21689280)

  • 1. The first 3 years of national bowel cancer screening at a single UK tertiary centre.
    Gupta S; Saunders BP; Fraser C; Kennedy RH; Ignjatovic A; Sala S; Marshall S; Suzuki N; Vance M; Thomas-Gibson S
    Colorectal Dis; 2012 Feb; 14(2):166-73. PubMed ID: 21689280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
    Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
    Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
    Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
    Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for colorectal cancer in Italy: 2005 survey.
    Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
    Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
    Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonoscopy conversion after flexible sigmoidoscopy screening: results from the UK Bowel Scope Screening Programme.
    Siau K; Yew AC; Ishaq S; Jewes S; Shetty S; Brookes M; Veitch A; McKaig B; Murugananthan A
    Colorectal Dis; 2018 Jun; 20(6):502-508. PubMed ID: 29205835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonneoplastic polypectomy during screening colonoscopy: the impact on polyp detection rate, adenoma detection rate, and overall cost.
    Atia MA; Patel NC; Ratuapli SK; Boroff ES; Crowell MD; Gurudu SR; Faigel DO; Leighton JA; Ramirez FC
    Gastrointest Endosc; 2015 Aug; 82(2):370-375.e1. PubMed ID: 25843614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies.
    Wieszczy P; Waldmann E; Løberg M; Regula J; Rupinski M; Bugajski M; Gray K; Kalager M; Ferlitsch M; Kaminski MF; Bretthauer M
    Gastroenterology; 2021 Mar; 160(4):1067-1074.e6. PubMed ID: 33065063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term risk of colorectal cancer in individuals with serrated polyps.
    Holme Ø; Bretthauer M; Eide TJ; Løberg EM; Grzyb K; Løberg M; Kalager M; Adami HO; Kjellevold Ø; Hoff G
    Gut; 2015 Jun; 64(6):929-36. PubMed ID: 25399542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in screening vs non-screening colonoscopy: scope for improvement?
    Ahmed S; Naumann DN; Karandikar S
    Colorectal Dis; 2016 Sep; 18(9):903-9. PubMed ID: 26850216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
    Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
    J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening.
    Liedenbaum MH; van Rijn AF; de Vries AH; Dekker HM; Thomeer M; van Marrewijk CJ; Hol L; Dijkgraaf MG; Fockens P; Bossuyt PM; Dekker E; Stoker J
    Gut; 2009 Sep; 58(9):1242-9. PubMed ID: 19625276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High quality of screening colonoscopy in Austria is not dependent on endoscopist specialty or setting.
    Kozbial K; Reinhart K; Heinze G; Zwatz C; Bannert C; Salzl P; Waldmann E; Britto-Arias M; Ferlitsch A; Trauner M; Weiss W; Ferlitsch M
    Endoscopy; 2015 Mar; 47(3):207-16. PubMed ID: 25412094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.